1. "2014"
Formats
  1. Journal Article (2603)
  2. Meeting Abstract (1417)
  3. Book Section (235)
  4. Conference Paper (23)
  5. Book Whole (16)
  6. Review (3)
Groups
  1. Department of Medicine (1584)
  2. GSK Faculty (1082)
  3. Surgery (895)
  4. Solid Tumor Oncology Division (840)
  5. Center for Hematologic Malignancies (703)
  6. Sloan Kettering Institute Faculty (672)

More Groups

People
  1. Jedd Wolchok (71)
  2. Sergio Giralt (71)
  3. Ross Levine (69)
  4. Martin Tallman (62)
  5. Michael Berger (59)
  6. Mithat Gonen (55)

More People

Years
  1. 2014 (4297)
Publications
  1. Journal of Clinical Oncology (420)
  2. Blood (228)
  3. International Journal of Radiation Oncology, Biology, Physics (131)
  4. Cancer Research (104)
  5. Modern Pathology (89)
  6. Laboratory Investigation (82)

More Publications

Publishers
  1. Elsevier Inc. (495)
  2. American Society of Clinical Oncology (446)
  3. Springer (318)
  4. Elsevier Science, Inc. (246)
  5. Nature Publishing Group (242)
  6. American Society of Hematology (230)

More Publishers

Results (4297)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hsp90 pharmacoproteomics: Harnessing pieiotropy for therapeutic synergy
    Meeting Abstract

    Goldstein, R.; Chiosis, G.; Cerchietti, L. C.; Melnick, A. M.
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Multi-arm, nonrandomized, open-label phase IB study to evaluate FP1039/GSK3052230 with chemotherapy in NSCLC and MPM with deregulated FGF pathway signaling
    Meeting Abstract

    Garrido, P.; Felip, E.; Delord, J. P.; Paz-Ares, L.; Barlesi, F.; Arkenau, H.; Lara, P.; Paik, P. K.; Morgensztern, D.; Gadgeel, S.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Correlation of clinical activity of pembrolizumab (MK-3475) with immunohistochemical staining for programmed death-1 ligand (PD-L1) in ≥50% of tumor cells in a prospective non-small cell lung cancer (NSCLC) validation population
    Meeting Abstract

    Garon, E. G.; Rizvi, N. A.; LeighI, N. B.; Hui, R.; Eder, J. P.; Patnaik, A.; Aggarwal, C.; Horn, L.; Balmanoukian, A. S.; Gubens, M. A.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • The Warburg effect confers adverse outcome in chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S. M.; Knapp, K.; Bauli, F.; Patel, M.; Lamanna, N.; Frattini, M. G.; Brentjens, R.; Maslak, P.; Jurcic, J. G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • TRC105 (anti-endoglin antibody) in combination with bevacizumab (BEV) and as a single agent for platinum resistant ovarian cancer
    Meeting Abstract

    Garcia, A. A.; Makker, V.; Spitz, D. L.; Matei, D. E.; Nick, A. M.; Landen, C. N.; Alvarez, E. A.; Mendelson, D. S.; Strother, R. M.; Seon, B. K.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Brentuximab vedotin in combination with CHP in patients (pts) with newly-diagnosed CD30+ peripheral T-cell lymphomas (PTCL): 2-year follow-up
    Meeting Abstract

    Fanale, M. A.; Horwitz, S. M.; Forero-Torres, A.; Bartlett, N. L.; Advani, R. H.; Pro, B.; Chen, R. W.; Davies, A.; Illidge, T.; Huebner, D.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • A first-in-human (FIH) safety and pharmacological study of SAR405838, a novel HDM2 antagonist, in patients with solid malignancies
    Meeting Abstract

    de Weger, V.; Lolkema, M. P.; Dickson, M.; Le Cesne, A.; Wagner, A.; Merqui-Roelvink, M.; Varga, A.; Tap, W.; Schwartz, G.; Demetri, G.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Elucidating a mitochondrial protective transcriptional network
    Meeting Abstract

    De Jesus, K. R.; Pellegrino, M.; Haynes, C.
    Abstracts of Papers of the American Chemical Society (2014)

    Fulltext@MSK | Save
  • Relationship between programmed death ligand 1 (PD-L1) expression and clinical outcome in patients (pts) with melanoma (MEL) treated with pembrolizumab (pembro; MK-3475)
    Meeting Abstract

    Daud, A.; Hamid, O.; Robert, C.; Hodi, F. S.; Wolchok, J. D.; Hwu, W. J.; Weber, J. S.; Kefford, R.; Hersey, P.; Joshua, A. M.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Development of xenoimplants from germline BRCA1/2 mutant breast cancer (BC) for the identification of predictive biomarkers, mechanisms of resistance against poly(ADP-ribose) polymerase (PARP) inhibitors and evaluation of novel therapies
    Meeting Abstract

    Cruz, C.; Ibrahim, Y.; Morancho, B.; Antón, P.; Grueso, J.; Cozar, P.; Guzman, M.; Aviles, P. M.; Guillen, M. J.; Galmarini, C.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save